Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Interim Management Statement

21 Jul 2014 07:00

RNS Number : 7841M
Standard Life Euro Pri Eqty Tst PLC
21 July 2014
 

Standard Life European Private Equity Trust PLC

 

Interim management statement for the quarter ended 30 June 2014

 

Standard Life European Private Equity Trust PLC ("the Company") presents its interim management statement for the period from 1 April 2014 to 30 June 2014. This announcement constitutes the Company's second interim management statement for the financial year ending 30 September 2014 in accordance with rule 4.3 of the UK Listing Authority's Disclosure and Transparency Rules. This interim statement summarises information at 30 June 2014 and any material developments up to 18 July 2014.

 

Investment objective

 

To achieve long-term capital gains through holding a diversified portfolio of private equity funds investing predominantly in Europe.

 

Benchmark

 

The Company has no defined benchmark.

 

Performance

 

The Company's net asset value per ordinary share ("NAV") was 252.2p and its net assets were £401.2 million at 31 March 2014. The Company's NAV at 30 June 2014 will be announced on or around 23 September 2014. The share price of the Company's ordinary shares was 215.0p at 30 June 2014, compared to 204.0p at 31 March 2014, an increase of 5.4% over the quarter.

 

Over the same quarter the MSCI Europe Index (in euros) rose by 2.6% and the FTSE All Share Index (in sterling) rose by 1.3%.

 

Financial position

 

During the quarter ended 30 June 2014 the Company funded £15.3 million of draw downs (six months ended 31 March 2014 - £15.9 million) and received £13.0 million of distributions (six months ended 31 March 2014 - £49.3 million). Draw down activity increased during the quarter as a result of new investment activity by a number of recent fund commitments, notably Permira V where draw downs totalled £5.2 million. While it was a quieter quarter for distributions, the Manager is aware of a number of exits having occurred where the Company is awaiting cash proceeds. As a result of the above, draw downs and distributions for the nine months ended 30 June 2014 were £31.2 million and £62.3 million, respectively.

 

The Company made no new fund commitments in the quarter ended 30 June 2014. The Company had total outstanding commitments to its 42 private equity fund interests of £192.0 million at 30 June 2014 (31 March 2014 - £213.5 million). The Manager continues to believe that up to £40 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

At 30 June 2014 the Company had a cash balance, including holdings in money market funds, of £18.1 million and had £22.0 million invested in UK and European equity index tracker funds (31 March 2014 - £22.7 million and £21.9 million, respectively). The Company continues to have an undrawn £80 million syndicated revolving credit facility led by The Royal Bank of Scotland plc that expires in December 2016.

 

 

Directorate changes

 

On 28 May 2014 the Company announced the appointment of Alan Devine to the Board as a non-executive director.

 

Alternative Investment Fund Managers Directive ("AIFMD" or "the Directive")

 

The Company is required to comply with the European Union AIFMD. The Directive requires the Company to appoint an Alternative Investment Fund Manager ("AIFM") who will be responsible for portfolio and risk management and will be regulated under the Directive. The Board has agreed to appoint SL Capital Partners LLP as the AIFM. The Directive also requires the Company to appoint a depositary and the Board has appointed BNP Paribas Securities Services to fulfil this function.

 

Events and transactions in the period to 18 July 2014

 

During the period from 30 June 2014 to 18 July 2014 the Company funded £5.4 million of draw downs and received £15.0 million of distributions. At 18 July 2014 the Company had a cash balance, including holdings in money market funds, of £26.2 million and had £21.6 million invested in UK and European equity index tracker funds.

 

The Company has also made a new commitment of €55.0 million to Altor IV, a Nordic mid-market buy-out fund.Accordingly, at 18 July 2014 the Company had outstanding commitments of £227.9 million.

 

 

For further information on the statement please contact:-

 

Peter McKellar of SL Capital Partners LLP (0131 245 0055)

 

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the London Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under Section 1158 of the Corporation Tax Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBUGDRGDBBGSI
Date   Source Headline
17th Jan 20207:00 amRNSDoc re. Annual Report
15th Jan 20207:00 amRNSMonth End Net Asset Value(s)
14th Jan 20204:18 pmRNSDirector/PDMR Shareholding
9th Jan 20207:00 amRNSAnnual Financial Report
6th Jan 202011:31 amRNSQuarterly Disclosure
13th Dec 20197:00 amRNSMonth End Net Asset Value(s)
12th Dec 20197:00 amRNSFourth Quarter Dividend Declaration
14th Nov 20197:00 amRNSMonth end Net Asset Value(s)
12th Nov 20194:22 pmRNSDirector/PDMR Shareholding
1st Nov 20192:45 pmRNSDirector/PDMR Shareholding
14th Oct 201911:00 amRNSMonth End Net Asset Value(s)
3rd Oct 201911:05 amRNSQuarterly Disclosure
27th Sep 20192:50 pmRNSEstimated Net Asset Value at 31 August 2019
27th Sep 20192:44 pmRNSQuarterly Trading Statement
12th Sep 20197:00 amRNSDeclaration of Third Quarter Dividend
29th Aug 20197:05 amRNSCompany Secretary Change
14th Aug 20192:24 pmRNSDirector/PDMR Shareholding
14th Aug 20197:00 amRNSEstimated Net Asset Value at 31 July 2019
5th Aug 201911:10 amRNSDirector Declaration
30th Jul 201910:53 amRNSDirector/PDMR Shareholding
12th Jul 20197:00 amRNSEstimated Net Asset Value at 30 June 2019
2nd Jul 20191:11 pmRNSQuarterly Disclosure
19th Jun 20197:06 amRNSEstimated Net Asset Value at 31 May 2019
19th Jun 20197:00 amRNSHalf-year Report
13th Jun 20197:00 amRNSDividend Declaration
29th May 201911:30 amRNSUpdate research from QuotedData
15th May 20197:00 amRNSEstimated Net Asset Value as at 30 April 2019
2nd May 201911:02 amRNSDirector/PDMR Shareholding
12th Apr 20197:00 amRNSEstimated Net Asset Value at 31 March 2019
2nd Apr 20193:55 pmRNSQuarterly Disclosure
1st Apr 201910:08 amRNSChange of Depositary
25th Mar 20197:00 amRNSEstimated net asset value as at 28 February 2019
25th Mar 20197:00 amRNSQuarterly Trading Statement
14th Mar 201911:31 amRNSEdison issues review on Standard Life Private
14th Mar 20197:00 amRNSDividend Declaration
14th Feb 20197:00 amRNSEstimated Net Asset Value at 31 January 2019
29th Jan 20194:27 pmRNSDirector/PDMR Shareholding
22nd Jan 20192:17 pmRNSResult of AGM
15th Jan 20197:00 amRNSEstimated Net Asset Value at 31 December 2018
3rd Jan 20192:17 pmRNSQuarterly Disclosure
31st Dec 201811:18 amRNSDividend Declaration
27th Dec 201811:03 amRNSDirector/PDMR Shareholding
18th Dec 201811:27 amRNS2018 Annual Report and AGM
14th Dec 20187:00 amRNSEstimated Net Asset Value at 30 November 2018
12th Dec 20187:00 amRNSAnnual Financial Report
7th Dec 20184:05 pmRNSDirectorate Change
14th Nov 20187:00 amRNSEstimated Net Asset Value at 31 October 2018
6th Nov 20183:27 pmRNSDirector/PDMR Shareholding
2nd Nov 201812:02 pmRNSDirector/PDMR Shareholding
12th Oct 20187:00 amRNSEstimated Net Asset Value at 30 September 2018

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.